The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125287692 12528769 2 F 2015 20160906 20160705 20160909 EXP PHHY2015IQ147580 NOVARTIS 41.21 YR F Y 0.00000 20160909 MD IQ IQ

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125287692 12528769 1 PS TASIGNA NILOTINIB 1 Oral 800 MG, QD U 22068 800 MG CAPSULE QD
125287692 12528769 2 C FOLIC ACID. FOLIC ACID 1 Oral 1 DF, QD U 0 1 DF TABLET QD
125287692 12528769 3 C CONCOR COR BISOPROLOL FUMARATE 1 Oral 2.5 MG, PRN (SOS) U 0 2.5 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125287692 12528769 1 Chronic myeloid leukaemia
125287692 12528769 2 Product used for unknown indication
125287692 12528769 3 Product used for unknown indication

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
125287692 12528769 Anaemia
125287692 12528769 Anxiety
125287692 12528769 Arthralgia
125287692 12528769 Bone pain
125287692 12528769 Cough
125287692 12528769 Dyspnoea
125287692 12528769 Erythema
125287692 12528769 Fatigue
125287692 12528769 Haemoglobin decreased
125287692 12528769 Hot flush
125287692 12528769 Hypersensitivity
125287692 12528769 Inappropriate schedule of drug administration
125287692 12528769 Increased appetite
125287692 12528769 Influenza
125287692 12528769 Nervousness
125287692 12528769 Pigmentation disorder
125287692 12528769 Pyrexia
125287692 12528769 Rash generalised
125287692 12528769 Tachycardia
125287692 12528769 Tracheal disorder
125287692 12528769 Weight increased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125287692 12528769 1 20150105 0